Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideELVElevance Health
FinDog View：Neutral
TMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | ELV | TMO |
|---|
| Close | 412.56 | 648.43 |
| Market Cap | $89.5B | $240B |
| 1M | +5.72% | +10.75% |
| P/E (TTM) | 18.2 | 34.4 |
| Forward P/E | 13.2 | 21.8 |
| P/E 5-Yr Percentile | 71 | 65 |
| P/S | 0.5 | 5.2 |
| P/B | 2.0 | 4.6 |
| Dividend Yield | 1.24% | 0.29% |
| Latest Quarter Revenue | $50.5B | $12.0B |
| Revenue YoY | +1.4% | +10.5% |
| Gross Margin | 89.1% | — |
| Latest Quarter EPS | 6.71 | 4.68 |
| Avg Post-Earnings Move | ±4.0% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 4.70% | 2.36% |
| 90-Day Net Insider Buying | +$1.4M | −$38.9M |
ELV · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
